logo

US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy

By: theblockbeats.news|2025/08/04 13:02:14

BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.


This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.

Прогноз цены Vaulta(A) Coin: Рост на 15% до $0.58 к апрелю 2025 – Достигнет ли $1?
Кошелек XRP, связанный с Chris Larsen, все еще имеет $9B на продажу, предупреждает аналитик

Вам также может понравиться

Поделиться
copy

Растущие активы

Последние новости криптовалют

02:58

AI News Today: Когда ИИ встречает блокчейн, возможности, которые нельзя упустить

00:59

Ethereum погружается ниже $2900

00:56

SOL Short-Term Price Drops Below $130

00:55

Powell Resignation Rumor Surfacing Again? Выступит с речью во вторник утром

00:53

A certain whale went 10x long on HYPE, with a position value exceeding $19 million, and a liquidation price of $25.724

Еще
Сообщество
icon
icon
icon
icon
icon
icon
icon
icon
icon
icon

Служба поддержки@weikecs

Деловое сотрудничество@weikecs

Количественная торговля и ММ[email protected]

VIP-программа[email protected]